NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Genprex Inc (NASDAQ: GNPX)

 
GNPX Technical Analysis
5
As on 21st Oct 2025 GNPX STOCK Price closed @ 11.50 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.17 & Strong Buy for SHORT-TERM with Stoploss of 2.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GNPXSTOCK Price

Open 12.97 Change Price %
High 12.97 1 Day 11.22 4007.14
Low 10.11 1 Week 11.29 5376.19
Close 11.50 1 Month 11.29 5376.19
Volume 256414 1 Year 9.06 371.31
52 Week High 3.15 | 52 Week Low 0.14
 
NASDAQ USA Most Active Stocks
BYND 3.62 146.26%
AMRS 0.14 100.00%
WBA 11.98 0.50%
NERV 6.41 140.98%
NVDA 181.16 -0.81%
RANI 2.85 26.67%
LMDX 0.02 0.00%
BITF 4.49 -9.84%
PLUG 3.12 -8.24%
ADAP 0.05 -16.67%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
GNPX 11.50 4007.14%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
EGRX 1.00 900.00%
CTXRW 0.14 600.00%
ORGS 0.89 493.33%
NDRAW 0.03 200.00%
 
NASDAQ USA Top Losers Stocks
COMSP 0.00 -100.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
OPI 0.06 -70.00%
OPI 0.06 -70.00%
AXAS 0.03 -70.00%
 
 
GNPX
Daily Charts
GNPX
Intraday Charts
Whats New @
Bazaartrend
GNPX
Free Analysis
 
GNPX Important Levels Intraday
RESISTANCE17.01
RESISTANCE15.24
RESISTANCE14.15
RESISTANCE13.06
SUPPORT9.94
SUPPORT8.85
SUPPORT7.76
SUPPORT5.99
 
GNPX Forecast October 2025
4th UP Forecast14.83
3rd UP Forecast13.76
2nd UP Forecast13.1
1st UP Forecast12.44
1st DOWN Forecast10.56
2nd DOWN Forecast9.9
3rd DOWN Forecast9.24
4th DOWN Forecast8.17
 
GNPX Weekly Forecast
4th UP Forecast12.62
3rd UP Forecast12.26
2nd UP Forecast12.04
1st UP Forecast11.82
1st DOWN Forecast11.18
2nd DOWN Forecast10.96
3rd DOWN Forecast10.74
4th DOWN Forecast10.38
 
GNPX Forecast2025
4th UP Forecast36.22
3rd UP Forecast28.29
2nd UP Forecast23.39
1st UP Forecast18.49
1st DOWN Forecast4.51
2nd DOWN Forecast-0.39
3rd DOWN Forecast-5.29
4th DOWN Forecast-13.22
 
 
GNPX Other Details
Segment EQ
Market Capital 109789448.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
GNPX Address
GNPX
 
GNPX Latest News
 
Your Comments and Response on Genprex Inc
 
GNPX Business Profile
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes who currently have limited treatment options. The company works with institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Its lead product candidate is REQORSA (GPX-001), which is in preclinical stage for the treatment of non-small cell lung cancer (NSCLC). It is also developing GPX-002, a preclinical stage gene therapy for diabetes. The company also offers ONCOPREX, a nanoparticle delivery system. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas. Address: 3300 Bee Cave Road, Austin, TX, United States, 78746
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service